Contact this trialFirst, we need to learn more about you.
WNT/β-catenin signaling pathway inhibitor
ST316 for Advanced Cancers
Recruiting1 awardPhase 1
New Orleans, Louisiana
This trial tests a new cancer drug to find if it's safe, how it works, and if it's effective against advanced solid tumors.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service